Expression of functional μ-opioid receptors during T cell development

被引:28
作者
McCarthy, L
Szabo, I
Nitsche, JF
Pintar, JE
Rogers, TJ
机构
[1] Temple Univ, Sch Med, Dept Microbiol & Immunol, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA
[2] Temple Univ, Sch Med, Ctr Subst Abuse, Philadelphia, PA 19140 USA
[3] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA
关键词
opioid receptor; chemotaxis; T cell development; thymus; opioid receptor knockout;
D O I
10.1016/S0165-5728(01)00248-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have examined the chemotactic responsiveness of thymocytes to selective mu-, kappa-, and delta -opioid agonists. Our results show that developing T cells migrate in response to mu- but not kappa- or delta -opioids. The mu -opioid response appears to be dependent on the classical mu -opioid receptor (MOR-1) since the chemotactic response is blocked by a selective mu -opioid antagonist, and is absent in thymocytes from MOR-l-deficient mice. Flow cytometric analysis of the mu -opioid responsive cells shows that these cells consist predominantly of highly immature CD4(-)CD8(-) T cells. These results represent the first demonstration of the functional expression of mu -opioid receptors by developing T cells. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:173 / 180
页数:8
相关论文
共 59 条
[1]   Inhibition of primary murine macrophage cytokine production in vitro following treatment with the kappa-opioid agonist U50,488H [J].
Alicea, C ;
Belkowski, S ;
Eisenstein, TK ;
Adler, MW ;
Rogers, TJ .
JOURNAL OF NEUROIMMUNOLOGY, 1996, 64 (01) :83-90
[2]   Characterization of κ-opioid receptor transcripts expressed by T cells and macrophages [J].
Alicea, C ;
Belkowski, SM ;
Sliker, JK ;
Zhu, JM ;
Liu-Chen, LY ;
Eisenstein, TK ;
Adler, MW ;
Rogers, TJ .
JOURNAL OF NEUROIMMUNOLOGY, 1998, 91 (1-2) :55-62
[3]   MORPHINE-INHIBITION OF LYMPHOCYTE ACTIVITY IS MEDIATED BY AN OPIOID DEPENDENT MECHANISM [J].
BAYER, BM ;
DAUSSIN, S ;
HERNANDEZ, M ;
IRVIN, L .
NEUROPHARMACOLOGY, 1990, 29 (04) :369-374
[4]  
BELKOWSKI SM, 1995, J PHARMACOL EXP THER, V273, P1491
[5]  
BELKOWSKI SM, 1995, ADV EXP MED BIOL, V373, P11
[6]   SEQUENCE OF KAPPA-OPIOID RECEPTOR CDNA IN THE R1.1 THYMOMA CELL-LINE [J].
BELKOWSKI, SM ;
ZHU, JM ;
LIUCHEN, LY ;
EISENSTEIN, TK ;
ADLER, MW ;
ROGERS, TJ .
JOURNAL OF NEUROIMMUNOLOGY, 1995, 62 (01) :113-117
[7]  
BenBaruch A, 1997, J IMMUNOL, V158, P5927
[8]  
BRYANT HU, 1990, J PHARMACOL EXP THER, V255, P410
[9]   EFFECTS OF INVIVO MORPHINE TREATMENT ON ANTIBODY-RESPONSES IN C57BL/6 BGJ/BGJ (BEIGE) MICE [J].
BUSSIERE, JL ;
ADLER, MW ;
ROGERS, TJ ;
EISENSTEIN, TK .
LIFE SCIENCES, 1993, 52 (04) :PL43-PL48
[10]   DIFFERENTIAL-EFFECTS OF MORPHINE AND NALTREXONE ON THE ANTIBODY-RESPONSE IN VARIOUS MOUSE STRAINS [J].
BUSSIERE, JL ;
ADLER, MW ;
ROGERS, TJ ;
EISENSTEIN, TK .
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1992, 14 (03) :657-673